Genetic variants in interleukin-18 gene and risk for cervical squamous cell carcinoma

Human Immunology

Volumn 74, Issue 7, 2013, Pages 882-887

  Yang, Yuh Cheng ^a,b   Chang, Tzu Yang ^a   Chen, Tze Chien ^a   Chang, Shih Chuan ^a   Lin, Wen Shan ^a   Lee, Yann Jinn ^a,b,c  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c MACKAY MEDICAL COLLEGE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 18;

ADULT; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWAN; UTERINE CERVIX CARCINOMA;

ADULT; CARCINOMA, SQUAMOUS CELL; DISEASE SUSCEPTIBILITY; DNA MUTATIONAL ANALYSIS; FEMALE; GENOTYPE; HUMANS; INTERLEUKIN-18; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, GENETIC; RISK; TAIWAN; UTERINE CERVICAL NEOPLASMS;

EID: 84878565126     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2013.04.001     Document Type: Article

References (47)

1. Chen C.A., Hsieh C.Y. Recent advances and problems in primary therapy for cervical cancer in Taiwan. J Formos Med Assoc 2004, 103:511-518.
2. zur Hausen H. Papillomaviruses and cancer from basic studies to clinical application. Nat Rev Cancer 2002, 2:342-350.
3. Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond) 2006, 110:525-541.
4. Okamura H., Tsutsi H., Komatsu T., Yutsudo M., Hakura A., Tanimoto T., et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995, 378:88-91.
5. Stoll S., Jonuleit H., Schmitt E., Muller G., Yamauchi H., Kurimoto M., et al. Production of functional IL-18 by different subtypes of murine and human dendritic cells (DC): DC-derived IL-18 enhances IL-12-dependent Th1 development. Eur J Immunol 1998, 28:3231-3239.
6. Nakanishi K., Yoshimoto T., Tsutsui H., Okamura H. Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 2001, 19:423-474.
7. Micallef M.J., Ohtsuki T., Kohno K., Tanabe F., Ushio S., Namba M., et al. Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production. Eur J Immunol 1996, 26:1647-1651.
8. Puren A.J., Fantuzzi G., Gu Y., Su M.S., Dinarello C.A. Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells. J Clin Invest 1998, 101:711-721.
9. Tsutsui H., Nakanishi K., Matsui K., Higashino K., Okamura H., Miyazawa Y., et al. IFN-gamma-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. J Immunol 1996, 157:3967-3973.
10. Dao T., Ohashi K., Kayano T., Kurimoto M., Okamura H. Interferon-gamma-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells. Cell Immunol 1996, 173:230-235.
11. Dao T., Mehal W.Z., Crispe I.N. IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells. J Immunol 1998, 161:2217-2222.
12. Kimura K., Kakimi K., Wieland S., Guidotti L.G., Chisari F.V. Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice. J Virol 2002, 76:10702-10707.
13. Wang Y., Chaudhri G., Jackson R.J., Karupiah G. IL-12p40 and IL-18 play pivotal roles in orchestrating the cell-mediated immune response to a poxvirus infection. J Immunol 2009, 183:3324-3331.
14. Osaki T., Peron J.M., Cai Q., Okamura H., Robbins P.D., Kurimoto M., et al. IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects. J Immunol 1998, 160:1742-1749.
15. Kikuchi T., Akasaki Y., Joki T., Abe T., Kurimoto M., Ohno T. Antitumor activity of interleukin-18 on mouse glioma cells. J Immunother 2000, 23:184-189.
16. Nolan K.F., Greaves D.R., Waldmann H. The human interleukin 18 gene IL18 maps to 11q22.2-q22.3, closely linked to the DRD2 gene locus and distinct from mapped IDDM loci. Genomics 1998, 51:161-163.
17. Giedraitis V., He B., Huang W.X., Hillert J. Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol 2001, 112:146-152.
18. Sanchez E., Palomino-Morales R.J., Ortego-Centeno N., Jimenez-Alonso J., Gonzalez-Gay M.A., Lopez-Nevot M.A., et al. Identification of a new putative functional IL18 gene variant through an association study in systemic lupus erythematosus. Hum Mol Genet 2009, 18:3739-3748.
19. Harada M., Obara K., Hirota T., Yoshimoto T., Hitomi Y., Sakashita M., et al. A functional polymorphism in IL-18 is associated with severity of bronchial asthma. Am J Respir Crit Care Med 2009, 180:1048-1055.
20. Arimitsu J., Hirano T., Higa S., Kawai M., Naka T., Ogata A., et al. IL-18 gene polymorphisms affect IL-18 production capability by monocytes. Biochem Biophys Res Commun 2006, 342:1413-1416.
21. Nikiteas N., Yannopoulos A., Chatzitheofylaktou A., Tsigris C. Heterozygosity for interleukin-18 -607 A/C polymorphism is associated with risk for colorectal cancer. Anticancer Res 2007, 27:3849-3853.
22. Liu Y., Lin N., Huang L., Xu Q., Pang G. Genetic polymorphisms of the interleukin-18 gene and risk of prostate cancer. DNA Cell Biol 2007, 26:613-618.
23. Wei Y.S., Lan Y., Liu Y.G., Tang H., Tang R.G., Wang J.C. Interleukin-18 gene promoter polymorphisms and the risk of esophageal squamous cell carcinoma. Acta Oncol 2007, 46:1090-1096.
24. Sobti R.C., Shekari M., Tamandani D.M., Malekzadeh K., Suri V. Association of interleukin-18 gene promoter polymorphism on the risk of cervix carcinogenesis in north Indian population. Oncol Res 2008, 17:159-166.
25. Haghshenas M.R., Hosseini S.V., Mahmoudi M., Saberi-Firozi M., Farjadian S., Ghaderi A. IL-18 serum level and IL-18 promoter gene polymorphism in Iranian patients with gastrointestinal cancers. J Gastroenterol Hepatol 2009, 24:1119-1122.
26. Farjadfar A., Mojtahedi Z., Ghayumi M.A., Erfani N., Haghshenas M.R., Ghaderi A. Interleukin-18 promoter polymorphism is associated with lung cancer: a case-control study. Acta Oncol 2009, 48:971-976.
27. Khalili-Azad T., Razmkhah M., Ghiam A.F., Doroudchi M., Talei A.R., Mojtahedi Z., et al. Association of interleukin-18 gene promoter polymorphisms with breast cancer. Neoplasma 2009, 56:22-25.
28. Cunha L.L., Tincani A.J., Assumpcao L.V., Soares F.A., Vassallo J., Ward L.S. Interleukin-10 but not interleukin-18 may be associated with the immune response against well-differentiated thyroid cancer. Clinics (Sao Paulo) 2011, 66:1203-1208.
29. Saenz-Lopez P., Carretero R., Vazquez F., Martin J., Sanchez E., Tallada M., et al. Impact of interleukin-18 polymorphisms-607 and -137 on clinical characteristics of renal cell carcinoma patients. Hum Immunol 2010, 71:309-313.
30. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
31. Chen Y.Y., You S.L., Chen C.A., Shih L.Y., Koong S.L., Chao K.Y., et al. Effectiveness of national cervical cancer screening programme in Taiwan: 12-year experiences. Br J Cancer 2009, 101:174-177.
32. Einstein M.H., Schiller J.T., Viscidi R.P., Strickler H.D., Coursaget P., Tan T., et al. Clinician's guide to human papillomavirus immunology: knowns and unknowns. Lancet Infect Dis 2009, 9:347-356.
33. O'Brien P.M. Saveria Campo M. Evasion of host immunity directed by papillomavirus-encoded proteins. Virus Res 2002, 88:103-117.
34. Ozsaran A.A., Ates T., Dikmen Y., Zeytinoglu A., Terek C., Erhan Y., et al. Evaluation of the risk of cervical intraepithelial neoplasia and human papilloma virus infection in renal transplant patients receiving immunosuppressive therapy. Eur J Gynaecol Oncol 1999, 20:127-130.
35. Serraino D., Carrieri P., Pradier C., Bidoli E., Dorrucci M., Ghetti E., et al. Risk of invasive cervical cancer among women with, or at risk for. HIV Infection Int J Cancer 1999, 82:334-337.
36. de Jong A., van Poelgeest M.I., van der Hulst J.M., Drijfhout J.W., Fleuren G.J., Melief C.J., et al. Human papillomavirus type 16-positive cervical cancer is associated with impaired CD4+ T-cell immunity against early antigens E2 and E6. Cancer Res 2004, 64:5449-5455.
37. Takeda K., Tsutsui H., Yoshimoto T., Adachi O., Yoshida N., Kishimoto T., et al. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 1998, 8:383-390.
38. Roth E., Pircher H. IFN-gamma promotes Fas ligand- and perforin-mediated liver cell destruction by cytotoxic CD8 T cells. J Immunol 2004, 172:1588-1594.
39. Takeda K., Hayakawa Y., Smyth M.J., Kayagaki N., Yamaguchi N., Kakuta S., et al. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nat Med 2001, 7:94-100.
40. Griffith T.S., Wiley S.R., Kubin M.Z., Sedger L.M., Maliszewski C.R., Fanger N.A. Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine. TRAIL J Exp Med 1999, 189:1343-1354.
41. Street D., Kaufmann A.M., Vaughan A., Fisher S.G., Hunter M., Schreckenberger C., et al. Interferon-gamma enhances susceptibility of cervical cancer cells to lysis by tumor-specific cytotoxic T cells. Gynecol Oncol 1997, 65:265-272.
42. Hougardy B.M., van der Zee A.G., van den Heuvel F.A., Timmer T., de Vries E.G., de Jong S. Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: relationship with Fas, caspase-8, and Bid. Gynecol Oncol 2005, 97:353-364.
43. Lee S.J., Cho Y.S., Cho M.C., Shim J.H., Lee K.A., Ko K.K., et al. Both E6 and E7 oncoproteins of human papillomavirus 16 inhibit IL-18-induced IFN-gamma production in human peripheral blood mononuclear and NK cells. J Immunol 2001, 167:497-504.
44. Cho Y.S., Kang J.W., Cho M., Cho C.W., Lee S., Choe Y.K., et al. Down modulation of IL-18 expression by human papillomavirus type 16 E6 oncogene via binding to IL-18. FEBS Lett 2001, 501:139-145.
45. Johnson G.C., Esposito L., Barratt B.J., Smith A.N., Heward J., Di Genova G., et al. Haplotype tagging for the identification of common disease genes. Nat Genet 2001, 29:233-237.
46. Cardon L.R., Bell J.I. Association study designs for complex diseases. Nat Rev Genet 2001, 2:91-99.
47. Hahn L.W., Ritchie M.D., Moore J.H. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 2003, 19:376-382.